ELEDON PHARMACEUTICALS INC. - COMMON STOCK

Eledon Announces Positive Topline Results from Phase 2a Trial of Tegoprubart Demonstrating Safety, Target Engagement, and Biomarker Response in Patients Living with Amyotrophic Lateral Sclerosis

31 مايو 2022 06:00:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports First Quarter 2022 Operating and Financial Results

12 مايو 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces First Patient Dosed in Phase 2a Trial Evaluating Tegoprubart in IgA Nephropathy

09 مايو 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022

05 مايو 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Participate in LifeSci Partners Immunology & Inflammation Symposium

03 مايو 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Participate in 18th Annual Noble Capital Markets Investor Conference

18 أبريل 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Eledon to Host Virtual R&D Day on Thursday, April 28, 2022

14 أبريل 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Operating and Financial Results

24 مارس 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 24, 2022

17 مارس 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals Provides Corporate Update and 2022 Outlook

14 فبراير 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Participate in 11th Annual SVB Leerink Global Healthcare Conference

08 فبراير 2022 16:05:00 بحسب Nasdaq GlobeNewswire